References analysis of the Wikipedia article "МОГ антителима изазвана болест" in the Serbian version

doi.org

Fan S, Xu Y, Ren H, et al. Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis. Mult Scler Relat Disord. 2018 Feb;Fan, Siyuan; Xu, Yan; Ren, Haitao; Guan, Hongzhi; Feng, Feng; Gao, Xuehui; Ding, Ding; Fang, Fang; Shan, Guangliang; Guan, Tianjia; Zhang, Yao; Dai, Yi; Yao, Ming; Peng, Bin; Zhu, Yicheng; Cui, Liying (2018). „Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis”. Multiple Sclerosis and Related Disorders. 20: 144—152. PMID 29414288. doi:10.1016/j.msard.2018.01.007.. Epub 2018 Jan 31.

Kezuka, Takeshi; Ishikawa, Hitoshi (2018). „Diagnosis and treatment of anti-myelin oligodendrocyte glycoprotein antibody positive optic neuritis”. Japanese Journal of Ophthalmology. 62 (2): 101—108. PMID 29445944. S2CID 3316963. doi:10.1007/s10384-018-0561-1.

Dos Passos, Giordani Rodrigues; Oliveira, Luana Michelli; Da Costa, Bruna Klein; Apostolos-Pereira, Samira Luisa; Callegaro, Dagoberto; Fujihara, Kazuo; Sato, Douglas Kazutoshi (2018). „MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned from Neuromyelitis Optica Spectrum Disorder”. Frontiers in Neurology. 9: 217. PMC 5893792 

. PMID 29670575. doi:10.3389/fneur.2018.00217 

Weber, Martin S.; Derfuss, Tobias; Metz, Imke; Brück, Wolfgang (2018). „Defining distinct features of anti-MOG antibody associated central nervous system demyelination”. Therapeutic Advances in Neurological Disorders. 11. PMC 5881972 

. PMID 29623106. doi:10.1177/1756286418762083.. eCollection 2018.

Ciotti, John R.; Eby, Noah S.; Wu, Gregory F.; Naismith, Robert T.; Chahin, Salim; Cross, Anne H. (2020-10-01). „Clinical and laboratory features distinguishing MOG antibody disease from multiple sclerosis and AQP4 antibody-positive neuromyelitis optica”. Multiple Sclerosis and Related Disorders (на језику: енглески). 45: 102399. ISSN 2211-0348. PMID 32702642. S2CID 224916747. doi:10.1016/j.msard.2020.102399.

Reindl, M; Di Pauli, F; Rostásy, K; Berger, T (август 2013). „The spectrum of MOG autoantibody-associated demyelinating diseases”. Nat Rev Neurol. 9 (8): 455—61. PMID 23797245. S2CID 7219279. doi:10.1038/nrneurol.2013.118.

Jarius, Sven; Paul, Friedemann; Weinshenker, Brian G.; Levy, Michael; Kim, Ho Jin; Wildemann, Brigitte (2020-10-22). „Neuromyelitis optica”. Nature Reviews. Disease Primers. 6 (1): 85. ISSN 2056-676X. PMID 33093467. S2CID 224825516. doi:10.1038/s41572-020-0214-9.

Hyun, Jae-Won; Woodhall, Mark R; Kim, Su-Hyun; Hye Jeong, In; Kong, Byungsoo; Kim, Gayoung; Kim, Yeseul; Su Park, Min; Irani, Sarosh R; Waters, Patrick; Jin Kim, Ho (2017). „Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases”. Journal of Neurology, Neurosurgery & Psychiatry. 88 (10): 811—817. PMID 28684532. S2CID 22732252. doi:10.1136/jnnp-2017-315998.

Baumann, M.; Hennes, E.M.; Schanda, K.; Karenfort, M.; Bajer-Kornek, B.; Diepold, K.; Fiedler, B.; Marquardt, I.; Strautmanis, J.; Vieker, S.; Reindl, M.; Rostásy, K. (2015). „Clinical characteristics and neuroradiological findings in children with multiphasic demyelinating encephalomyelitis and MOG antibodies”. European Journal of Paediatric Neurology. 19 (Supplement 1): S21. doi:10.1016/S1090-3798(15)30066-0.

Di Pauli, F. (2015). „Fulminant demyelinating encephalomyelitis: Insights from antibody studies and neuropathology”. Neurology: Neuroimmunology. 2 (6): e175. PMC 4635550 

. PMID 26587556. doi:10.1212/NXI.0000000000000175 

Spadaro, Melania (2016). „Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis”. Neurology - Neuroimmunology Neuroinflammation. 3 (5): e257. PMC 4949775 

. PMID 27458601. doi:10.1212/NXI.0000000000000257.

Tajfirouz, Deena A.; Bhatti, M. Tariq; Chen, John J. (2019). „Clinical Characteristics and Treatment of MOG-IgG–Associated Optic Neuritis”. Current Neurology and Neuroscience Reports. 19 (12): 100. PMID 31773369. S2CID 208278781. doi:10.1007/s11910-019-1014-z.

Reindl, M; Di Pauli, F; Rostásy, K; Berger, T (Aug 2013). "The spectrum of MOG autoantibody-associated demyelinating diseases". Nat Rev Neurol. Reindl, Markus; Di Pauli, Franziska; Rostásy, Kevin; Berger, Thomas (2013). „The spectrum of MOG autoantibody-associated demyelinating diseases”. Nature Reviews Neurology. 9 (8): 455—461. PMID 23797245. S2CID 7219279. doi:10.1038/nrneurol.2013.118.

Tajfirouz, Deena A.; Bhatti, M. Tariq; Chen, John J. (26. 11. 2019). „Clinical Characteristics and Treatment of MOG-IgG–Associated Optic Neuritis”. Current Neurology and Neuroscience Reports. 19 (12): 100. PMID 31773369. S2CID 208278781. doi:10.1007/s11910-019-1014-z.

Narayan, Ram N; Wang, Cynthia; Sguigna, Peter; Husari, Khalil; Greenberg, Benjamin (2019). „Atypical Anti-MOG syndrome with aseptic meningoencephalitis and pseudotumor cerebri-like presentations”. Multiple Sclerosis and Related Disorders. 27: 30—33. PMID 30300850. S2CID 52957303. doi:10.1016/j.msard.2018.10.003.

de Mol, CL; Wong, YYM; van Pelt, ED; Wokke, BHA; Siepman, TAM; Neuteboom, RF; Hamann, D; Hintzen, RQ (16. 5. 2019). „The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults”. Multiple Sclerosis Journal. 26 (7): 806—814. PMC 7294530 

. PMID 31094288. doi:10.1177/1352458519845112 

Spadaro, Melania; Gerdes, Lisa Ann; Mayer, Marie C.; Ertl-Wagner, Birgit; Laurent, Sarah; Krumbholz, Markus; Breithaupt, Constanze; Högen, Tobias; Straube, Andreas; Giese, Armin; Hohlfeld, Reinhard; Lassmann, Hans; Meinl, Edgar; Kümpfel, Tania (2015). „Histopathology and clinical course of MOG-antibody-associated encephalomyelitis”. Annals of Clinical and Translational Neurology. 2 (3): 295—301. PMC 4369279 

. PMID 25815356. doi:10.1002/acn3.164..

Jarius, S.; Paul, F.; Aktas, O.; Asgari, N.; Dale, R. C.; De Seze, J.; Franciotta, D.; Fujihara, K.; Jacob, A.; Kim, H. J.; Kleiter, I.; Kümpfel, T.; Levy, M.; Palace, J.; Ruprecht, K.; Saiz, A.; Trebst, C.; Weinshenker, B. G.; Wildemann, B. (2018). „MOG encephalomyelitis: International recommendations on diagnosis and antibody testing”. Journal of Neuroinflammation. 15 (1): 134. PMC 5932838 

. PMID 29724224. doi:10.1186/s12974-018-1144-2 

Nakashima, Ichiro (2015). „Anti‐myelin oligodendrocyte glycoprotein antibody in demyelinating diseases”. Clinical and Experimental Neuroimmunology. 6: 59—63. S2CID 74183244. doi:10.1111/cen3.12262.

Jarius, Sven; Pellkofer, Hannah; Siebert, Nadja; Korporal-Kuhnke, Mirjam; Hümmert, Martin W.; Ringelstein, Marius; Rommer, Paulus S.; Ayzenberg, Ilya; Ruprecht, Klemens; Klotz, Luisa; Asgari, Nasrin; Zrzavy, Tobias; Höftberger, Romana; Tobia, Rafik; Buttmann, Mathias; Fechner, Kai; Schanda, Kathrin; Weber, Martin; Asseyer, Susanna; Haas, Jürgen; Lechner, Christian; Kleiter, Ingo; Aktas, Orhan; Trebst, Corinna; Rostasy, Kevin; Reindl, Markus; Kümpfel, Tania; Paul, Friedemann; Wildemann, Brigitte; in cooperation with the Neuromyelitis Optica Study Group (NEMOS) (2020). „Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients”. Journal of Neuroinflammation. 17 (1): 261. PMC 7470615 

. PMID 32883348. doi:10.1186/s12974-020-01824-2 

Jarius, Sven; et al. (2020). „Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients”. Journal of Neuroinflammation. 17 (1): 262. PMC 7470445 

. PMID 32883358. doi:10.1186/s12974-020-01825-1 

. PMID 29724224. doi:10.1186/s12974-018-1144-2 

Jurynczyk, Maciej; Geraldes, Ruth; Probert, Fay; Woodhall, Mark R.; Waters, Patrick; Tackley, George; Deluca, Gabriele; Chandratre, Saleel; Leite, Maria I.; Vincent, Angela; Palace, Jacqueline (2017). „Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis”. Brain. 140 (3): 617—627. PMID 28364548. doi:10.1093/brain/aww350.

Pérez, Carlos A.; Garcia-Tarodo, Stephanie; Troxell, Regina (2019). „MRI-Negative Myelitis Associated with Myelin Oligodendrocyte Glycoprotein Antibody Spectrum Demyelinating Disease”. Child Neurology Open. 6: 2329048X1983047. PMC 6379793 

. PMID 30800700. doi:10.1177/2329048X19830475.

Hacohen, Yael; Wong, Yu Yi; Lechner, Christian; Jurynczyk, Maciej; Wright, Sukhvir; Konuskan, Bahadir; Kalser, Judith; Poulat, Anne Lise; Maurey, Helene; Ganelin-Cohen, Esther; Wassmer, Evangeline; Hemingway, Chery; Forsyth, Rob; Hennes, Eva Maria; Leite, M. Isabel; Ciccarelli, Olga; Anlar, Banu; Hintzen, Rogier; Marignier, Romain; Palace, Jacqueline; Baumann, Matthias; Rostásy, Kevin; Neuteboom, Rinze; Deiva, Kumaran; Lim, Ming (2018). „Disease Course and Treatment Responses in Children with Relapsing Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease”. JAMA Neurology. 75 (4): 478—487. PMC 5885190 

. PMID 29305608. doi:10.1001/jamaneurol.2017.4601..

Cherin, Patrick; Marie, Isabelle; Michallet, Mauricette; Pelus, Eric; Dantal, Jacques; Crave, Jean-Charles; Delain, Jean-Christophe; Viallard, Jean-François (2016). „Management of adverse events in the treatment of patients with immunoglobulin therapy: A review of evidence”. Autoimmunity Reviews. 15 (1): 71—81. PMID 26384525. doi:10.1016/j.autrev.2015.09.002.

nih.gov

ncbi.nlm.nih.gov